The aim of this single-blind randomized controlled trial is to compare the effects of two therapies-neuromuscular electrical stimulation (NMES) and electromyographic (EMG) biofeedback-in stroke patients with shoulder (glenohumeral) subluxation. The study will evaluate changes in shoulder structure and function by measuring the acromion-greater tuberosity distance, supraspinatus and posterior deltoid muscle thickness, shoulder range of motion, and Brunnstrom stage of the upper extremity and hand. Clinical outcomes such as shoulder pain, stroke-specific quality of life, and the Shoulder Pain and Disability Index (SPADI) will also be assessed. This trial is designed to provide evidence on which therapy may be more effective for improving shoulder stability, reducing pain, and enhancing quality of life in stroke survivors with shoulder subluxation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Acromion-Greater Tuberosity Distance (AGT Distance) - Musculoskeletal Ultrasound Measurement
Timeframe: Baseline and Week 3
Supraspinatus Muscle Thickness Measured by Musculoskeletal Ultrasound
Timeframe: Baseline (Week 0) and Week 3
Posterior Deltoid Muscle Thickness Measured by Musculoskeletal Ultrasound
Timeframe: Baseline (Week 0) and Week 3
Motor Function
Timeframe: Baseline and Week 3